[8-K] Cardinal Health, Inc. Reports Material Event
Cardinal Health, Inc. filed an 8-K reporting execution of a Third Supplemental Indenture dated August 27, 2025, with The Bank of New York Mellon Trust Company, N.A., as trustee, and included forms of two note series: 4.500% Notes due 2030 and 5.150% Notes due 2035. The filing incorporates the original Indenture dated June 2, 2008, and includes legal opinions and consents from Cardinal Health's General Counsel and White & Case LLP, plus an embedded Inline XBRL cover page.
The disclosure documents appear to support issuance or amendment of long-term debt instruments by the company and provide legal and trustee documentation required for such securities. The filing is signed by Aaron E. Alt, Chief Financial Officer.
Cardinal Health, Inc. ha depositato un modulo 8-K che rende nota l'esecuzione di un Third Supplemental Indenture datato 27 agosto 2025 con The Bank of New York Mellon Trust Company, N.A., in qualità di trustee, e allega i moduli relativi a due serie di obbligazioni: le 4,500% Notes in scadenza 2030 e le 5,150% Notes in scadenza 2035. Il documento integra l'Indenture originale datato 2 giugno 2008 e include pareri legali e consensi del General Counsel di Cardinal Health e di White & Case LLP, oltre a una pagina di copertina Inline XBRL incorporata.
I documenti divulgativi sembrano supportare l'emissione o la modifica di strumenti di debito a lungo termine da parte della società e forniscono la documentazione legale e del trustee necessaria per tali titoli. Il filing è firmato da Aaron E. Alt, Chief Financial Officer.
Cardinal Health, Inc. presentó un formulario 8-K en el que informa la ejecución de un Third Supplemental Indenture con fecha 27 de agosto de 2025 con The Bank of New York Mellon Trust Company, N.A. como fiduciario, e incluye los modelos de dos series de pagarés: Notas 4,500% con vencimiento en 2030 y Notas 5,150% con vencimiento en 2035. El informe incorpora el Indenture original fechado el 2 de junio de 2008 y adjunta opiniones legales y consentimientos del General Counsel de Cardinal Health y de White & Case LLP, además de una portada Inline XBRL incrustada.
Los documentos de divulgación parecen respaldar la emisión o modificación de instrumentos de deuda a largo plazo por parte de la compañía y proporcionan la documentación legal y del fiduciario requerida para dichos valores. La presentación está firmada por Aaron E. Alt, Chief Financial Officer.
Cardinal Health, Inc.는 2025년 8월 27일자 제3차 보충 계약(Third Supplemental Indenture)을 수탁자(The Bank of New York Mellon Trust Company, N.A.)와 체결했음을 보고하는 8-K를 제출했으며, 두 개의 채권 시리즈 서식인 2030 만기 4.500% 채권 및 2035 만기 5.150% 채권 양식을 포함했습니다. 이번 제출서는 2008년 6월 2일자 원래 Indenture를 편입하고 있으며, Cardinal Health의 법무책임자(General Counsel)와 White & Case LLP의 법률 의견서 및 동의서, 그리고 포함된 Inline XBRL 표지 페이지를 포함합니다.
공개 문서는 회사의 장기 부채성 증권 발행 또는 수정에 대한 근거를 제공하는 것으로 보이며, 그러한 증권에 필요한 법적 문서와 수탁자 관련 문서를 제공합니다. 해당 제출서는 최고재무책임자(CFO) Aaron E. Alt가 서명했습니다.
Cardinal Health, Inc. a déposé un formulaire 8-K faisant état de l'exécution d'un Third Supplemental Indenture daté du 27 août 2025 avec The Bank of New York Mellon Trust Company, N.A. en tant que trustee, et a joint les modèles correspondant à deux séries de titres : Notes 4,500% échéance 2030 et Notes 5,150% échéance 2035. Le dépôt intègre l'Indenture original daté du 2 juin 2008 et comprend des avis juridiques et consentements du General Counsel de Cardinal Health et de White & Case LLP, ainsi qu'une page de couverture Inline XBRL intégrée.
Les documents de divulgation semblent appuyer l'émission ou la modification d'instruments de dette à long terme par la société et fournissent la documentation juridique et relative au trustee requise pour ces titres. Le dépôt est signé par Aaron E. Alt, Chief Financial Officer.
Cardinal Health, Inc. reichte ein 8-K ein, das die Ausführung einer Third Supplemental Indenture vom 27. August 2025 mit The Bank of New York Mellon Trust Company, N.A. als Treuhänder meldet, und legte Muster für zwei Schuldverschreibungsserien bei: 4,500% Notes fällig 2030 und 5,150% Notes fällig 2035. Die Einreichung nimmt die ursprüngliche Indenture vom 2. Juni 2008 auf und enthält rechtliche Stellungnahmen und Zustimmungen des General Counsel von Cardinal Health sowie von White & Case LLP sowie eine eingebettete Inline XBRL-Titelseite.
Die Offenlegungsunterlagen scheinen die Ausgabe oder Änderung von langfristigen Schuldinstrumenten durch das Unternehmen zu unterstützen und liefern die hierfür erforderlichen rechtlichen und treuhänderischen Dokumente. Die Einreichung ist von Aaron E. Alt, Chief Financial Officer, unterzeichnet.
- Documented legal and trustee framework for the notes through a Third Supplemental Indenture and trustee involvement
- Clear coupon and maturity terms4.500% due 2030 and 5.150% due 2035
- Legal opinions and consents included from Cardinal Healths General Counsel and White & Case LLP, supporting compliance
- Additional long-term fixed-rate obligations implied by the note forms, which could increase future interest expense
- Key transactional details missing from the filing (principal amounts, pricing, use of proceeds, covenants), limiting assessment of financial impact
Insights
TL;DR: Cardinal Health executed a supplemental indenture and provided forms for two fixed-rate note series, indicating new or restructured long-term debt.
The filing documents a Third Supplemental Indenture and includes forms for a 4.500% note maturing 2030 and a 5.150% note maturing 2035, together with legal opinions and trustee arrangements. For investors, the items materially relate to the companys capital structure and potential interest expense profile because the stated coupons are fixed rates over multi-year maturities. The filing itself does not disclose principal sizes, use of proceeds, or pricing beyond coupon and maturity, so materiality to valuation depends on the eventual offering size and terms which are not included here.
TL;DR: Proper legal consents and trustee documentation accompany a supplemental indenture and note forms, reflecting governance and compliance steps for debt issuance.
The 8-K includes the original indenture reference, a Third Supplemental Indenture dated August 27, 2025, legal opinions from in-house counsel and White & Case LLP, and consents included as exhibits. These items complete the documentary record required for registering or issuing debt under the indenture framework. The filing confirms formal execution and counsel sign-off but does not provide transaction economics or covenants beyond the note coupons and maturities.
Cardinal Health, Inc. ha depositato un modulo 8-K che rende nota l'esecuzione di un Third Supplemental Indenture datato 27 agosto 2025 con The Bank of New York Mellon Trust Company, N.A., in qualità di trustee, e allega i moduli relativi a due serie di obbligazioni: le 4,500% Notes in scadenza 2030 e le 5,150% Notes in scadenza 2035. Il documento integra l'Indenture originale datato 2 giugno 2008 e include pareri legali e consensi del General Counsel di Cardinal Health e di White & Case LLP, oltre a una pagina di copertina Inline XBRL incorporata.
I documenti divulgativi sembrano supportare l'emissione o la modifica di strumenti di debito a lungo termine da parte della società e forniscono la documentazione legale e del trustee necessaria per tali titoli. Il filing è firmato da Aaron E. Alt, Chief Financial Officer.
Cardinal Health, Inc. presentó un formulario 8-K en el que informa la ejecución de un Third Supplemental Indenture con fecha 27 de agosto de 2025 con The Bank of New York Mellon Trust Company, N.A. como fiduciario, e incluye los modelos de dos series de pagarés: Notas 4,500% con vencimiento en 2030 y Notas 5,150% con vencimiento en 2035. El informe incorpora el Indenture original fechado el 2 de junio de 2008 y adjunta opiniones legales y consentimientos del General Counsel de Cardinal Health y de White & Case LLP, además de una portada Inline XBRL incrustada.
Los documentos de divulgación parecen respaldar la emisión o modificación de instrumentos de deuda a largo plazo por parte de la compañía y proporcionan la documentación legal y del fiduciario requerida para dichos valores. La presentación está firmada por Aaron E. Alt, Chief Financial Officer.
Cardinal Health, Inc.는 2025년 8월 27일자 제3차 보충 계약(Third Supplemental Indenture)을 수탁자(The Bank of New York Mellon Trust Company, N.A.)와 체결했음을 보고하는 8-K를 제출했으며, 두 개의 채권 시리즈 서식인 2030 만기 4.500% 채권 및 2035 만기 5.150% 채권 양식을 포함했습니다. 이번 제출서는 2008년 6월 2일자 원래 Indenture를 편입하고 있으며, Cardinal Health의 법무책임자(General Counsel)와 White & Case LLP의 법률 의견서 및 동의서, 그리고 포함된 Inline XBRL 표지 페이지를 포함합니다.
공개 문서는 회사의 장기 부채성 증권 발행 또는 수정에 대한 근거를 제공하는 것으로 보이며, 그러한 증권에 필요한 법적 문서와 수탁자 관련 문서를 제공합니다. 해당 제출서는 최고재무책임자(CFO) Aaron E. Alt가 서명했습니다.
Cardinal Health, Inc. a déposé un formulaire 8-K faisant état de l'exécution d'un Third Supplemental Indenture daté du 27 août 2025 avec The Bank of New York Mellon Trust Company, N.A. en tant que trustee, et a joint les modèles correspondant à deux séries de titres : Notes 4,500% échéance 2030 et Notes 5,150% échéance 2035. Le dépôt intègre l'Indenture original daté du 2 juin 2008 et comprend des avis juridiques et consentements du General Counsel de Cardinal Health et de White & Case LLP, ainsi qu'une page de couverture Inline XBRL intégrée.
Les documents de divulgation semblent appuyer l'émission ou la modification d'instruments de dette à long terme par la société et fournissent la documentation juridique et relative au trustee requise pour ces titres. Le dépôt est signé par Aaron E. Alt, Chief Financial Officer.
Cardinal Health, Inc. reichte ein 8-K ein, das die Ausführung einer Third Supplemental Indenture vom 27. August 2025 mit The Bank of New York Mellon Trust Company, N.A. als Treuhänder meldet, und legte Muster für zwei Schuldverschreibungsserien bei: 4,500% Notes fällig 2030 und 5,150% Notes fällig 2035. Die Einreichung nimmt die ursprüngliche Indenture vom 2. Juni 2008 auf und enthält rechtliche Stellungnahmen und Zustimmungen des General Counsel von Cardinal Health sowie von White & Case LLP sowie eine eingebettete Inline XBRL-Titelseite.
Die Offenlegungsunterlagen scheinen die Ausgabe oder Änderung von langfristigen Schuldinstrumenten durch das Unternehmen zu unterstützen und liefern die hierfür erforderlichen rechtlichen und treuhänderischen Dokumente. Die Einreichung ist von Aaron E. Alt, Chief Financial Officer, unterzeichnet.